Aclaris Therapeutics (ACRS) News Headlines

▮ More

Date

Headline

7/20/2020 11:15:48 AM Stock Alert: Aclaris Therapeutics Up 40%

6/17/2020 7:35:00 AM Aclaris Says FDA Clears IND To Evaluate ATI-450 MK2 Inhibitor - Quick Facts

6/17/2020 7:09:37 AM Aclaris Therapeutics Says FDA Allows IND To Study ATI-450 In Hospitalized Patients With COVID-19

1/8/2020 8:20:23 AM Aclaris Therapeutics Names Vincent Milano To Board

10/11/2019 5:54:17 AM MITO Empowered, FPRX Cuts Another 70 Jobs, Second Death In Legionnaires Outbreak

9/19/2019 10:58:50 PM 5 Top Losers In Healthcare Sector (NSPR, NTEC, ACRS…)

9/19/2019 12:22:53 AM 5 Top Losers In Healthcare Sector (ZYNE, PTCT, MRNS…)

9/17/2019 10:09:39 PM 6 Top Gainers In Healthcare Sector (ACRS, NSPR, AVDL…)

9/17/2019 4:09:51 AM XLRN Pulls The Plug On FSHD Study, KPTI Well Funded, ACRS Up On Wart Trial Data

9/5/2019 8:34:40 AM Aclaris Therapeutics Announces Completion Of Strategic Review Of Its Business

8/1/2019 12:02:07 AM 5 Top Losers In Healthcare Sector (TTOO, LXRX, ACRS…)

7/31/2019 5:05:55 AM ACRS On Watch, Avita, Exicure For The Long Haul, VCYT, NUVA Lift Outlook

7/3/2019 4:06:22 PM Aclaris Therapeutics Appoints Maxine Gowen To Board Of Directors

6/17/2019 6:13:43 AM Aclaris Therapeutics Announces Positive 6-Month Results From A Phase 2 Open-Label Clinical Trial Of ATI-502

6/16/2019 3:45:00 AM Will These 5 Biotechs Hit The Bull's-Eye Or Miss The Mark?

12/3/2018 7:19:03 AM Aclaris Therapeutics Closes Acquisition Of Worldwide Rights To RHOFADE Cream, 1%

10/22/2018 4:11:03 PM Aclaris Therapeutics Closes Public Offering Of 9.94 Mln Shares At $10.75/Shr

10/17/2018 9:54:19 PM Aclaris Therapeutics Prices Public Offering Of 8.65 Mln Shares At $10.75/shr

10/17/2018 4:57:34 PM Aclaris Therapeutics (ACRS) Is Heading Lower After Offering Announcement

10/17/2018 4:01:57 PM Aclaris Therapeutics Intends To Offer And Sell Shares Of Its Common Stock

Latest Headlines